Development of (6R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis

Publication Date:
2018-03-07
Publisher:
American Chemical Society (ACS)
Topics:
Chemistry and Pharmacology
Published by:
http://www.acs.org/
_version_ 1836398833024630784
autor Andrew M. Thompson, Patrick D. O’Connor, Andrew J. Marshall, Adrian Blaser, Vanessa Yardley, Louis Maes, Suman Gupta, Delphine Launay, Stephanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper and William A. Denny
beschreibung Journal of Medicinal Chemistry DOI: 10.1021/acs.jmedchem.7b01581
citation_standardnr 6197050
datenlieferant ipn_articles
feed_id 1798
feed_publisher American Chemical Society (ACS)
feed_publisher_url http://www.acs.org/
insertion_date 2018-03-07
publikationsjahr_anzeige 2018
publikationsjahr_facette 2018
publikationsjahr_intervall 7984:2015-2019
publikationsjahr_sort 2018
publisher American Chemical Society (ACS)
quelle Journal of Medicinal Chemistry
relation http://feedproxy.google.com/~r/acs/jmcmar/~3/7HaPNiBhL1E/acs.jmedchem.7b01581
search_space articles
shingle_author_1 Andrew M. Thompson, Patrick D. O’Connor, Andrew J. Marshall, Adrian Blaser, Vanessa Yardley, Louis Maes, Suman Gupta, Delphine Launay, Stephanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper and William A. Denny
shingle_author_2 Andrew M. Thompson, Patrick D. O’Connor, Andrew J. Marshall, Adrian Blaser, Vanessa Yardley, Louis Maes, Suman Gupta, Delphine Launay, Stephanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper and William A. Denny
shingle_author_3 Andrew M. Thompson, Patrick D. O’Connor, Andrew J. Marshall, Adrian Blaser, Vanessa Yardley, Louis Maes, Suman Gupta, Delphine Launay, Stephanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper and William A. Denny
shingle_author_4 Andrew M. Thompson, Patrick D. O’Connor, Andrew J. Marshall, Adrian Blaser, Vanessa Yardley, Louis Maes, Suman Gupta, Delphine Launay, Stephanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper and William A. Denny
shingle_catch_all_1 Development of (6R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis
Journal of Medicinal Chemistry DOI: 10.1021/acs.jmedchem.7b01581
Andrew M. Thompson, Patrick D. O’Connor, Andrew J. Marshall, Adrian Blaser, Vanessa Yardley, Louis Maes, Suman Gupta, Delphine Launay, Stephanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper and William A. Denny
American Chemical Society (ACS)
shingle_catch_all_2 Development of (6R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis
Journal of Medicinal Chemistry DOI: 10.1021/acs.jmedchem.7b01581
Andrew M. Thompson, Patrick D. O’Connor, Andrew J. Marshall, Adrian Blaser, Vanessa Yardley, Louis Maes, Suman Gupta, Delphine Launay, Stephanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper and William A. Denny
American Chemical Society (ACS)
shingle_catch_all_3 Development of (6R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis
Journal of Medicinal Chemistry DOI: 10.1021/acs.jmedchem.7b01581
Andrew M. Thompson, Patrick D. O’Connor, Andrew J. Marshall, Adrian Blaser, Vanessa Yardley, Louis Maes, Suman Gupta, Delphine Launay, Stephanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper and William A. Denny
American Chemical Society (ACS)
shingle_catch_all_4 Development of (6R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis
Journal of Medicinal Chemistry DOI: 10.1021/acs.jmedchem.7b01581
Andrew M. Thompson, Patrick D. O’Connor, Andrew J. Marshall, Adrian Blaser, Vanessa Yardley, Louis Maes, Suman Gupta, Delphine Launay, Stephanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper and William A. Denny
American Chemical Society (ACS)
shingle_title_1 Development of (6R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis
shingle_title_2 Development of (6R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis
shingle_title_3 Development of (6R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis
shingle_title_4 Development of (6R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis
timestamp 2025-06-30T23:33:21.316Z
titel Development of (6R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis
titel_suche Development of (6R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis
topic V
uid ipn_articles_6197050